In a systematic review of prospective studies that performed bone avid tracer cardiac scintigraphy screening for TTR cardiac amyloidosis in different populations at risk, the authors identified 156 patients (11%) with ATTR-CM in the nine studies published between 2015 and 2020 and accounting for 1,375 screened patients. This evidence concerns the gene TTR and cardiac amyloidosis.